U.S. Acute Care Procedure Chair Market (2025 - 2033)

U.S. Acute Care Procedure Chair Market Summary

The U.S. acute care procedure chair market size was estimated at USD 96.16 million in 2024 and is expected to grow at a CAGR of 7.38% from 2025 to 2033 to reach USD 182.38 million by 2033. This growth can be attributed to the rising volume of outpatient and emergency procedures, increasing demand for workflow-efficient patient handling solutions, expanding adoption of ergonomically advanced chairs in ambulatory surgery centers and hospital emergency departments, and growing emphasis on infection-control-compliant, multifunctional equipment that supports rapid patient turnover and improved clinical outcomes.

Rising hospitalization rates in the U.S. are driving up demand for acute care procedure chairs. The growing burden of diseases, surgical interventions, and age-related health conditions has led to more patients requiring inpatient care. As hospitals experience higher patient volumes, the need for efficient, adaptable, and comfortable procedure chairs increases to support examinations, treatments, and routine clinical workflows. This trend is expected to further strengthen market growth in the years to come.

In recent years, the country has witnessed growth in admissions in community hospitals and other hospitals.

Thus, the rise in hospital admissions across the U.S. increases the number of patients requiring examinations, treatments, and short-term care, as a result, strengthening the demand for acute care procedure chairs and supporting market growth as healthcare facilities manage higher patient volumes.

Moreover, the rising burden of road accidents and sports injuries is expected to drive market growth. These incidents often require surgical procedures, increasing demand for multifunctional treatment and stretcher chairs. According to the National Safety Council, approximately 46,027 individuals died in motor vehicle crashes in the U.S. in 2022, and medically consulted injuries from such incidents totaled 5.2 million that year.

According to the National Safety Council, about 3.7 million people were treated in emergency departments for injuries related to recreational and sports equipment in 2023. The Council also reports that sports and recreational injuries rose by 20% in 2021, 12% in 2022, and 2% in 2023. As a result, demand for acute care procedure chairs is expected to increase. In addition, the National Highway Traffic Safety Administration reported a 1.8% rise in injury crashes from 2022 to 2023.

State-by-state motor vehicle crash fatalities and fatalities per 100,000 population, 2023

Source: Insurance Institute for Highway Safety, Highway Loss Data Institute

As a result, the substantial number of individuals affected by road-traffic accidents and sports-related injuries is expected to drive demand for acute care procedure chairs in the coming years.

Market Concentration & Characteristics

The U.S. acute care procedure chair industry is expanding steadily as hospitals, outpatient centers, and emergency departments increasingly adopt ergonomic, workflow-efficient chairs that enhance patient handling, reduce clinician strain, and support high procedural throughput. Growth is fueled by rising hospitalization rates, increasing volumes of outpatient and emergency procedures, a shift toward minimally invasive treatments, and a widening adoption of powered, multi-position chairs across care settings.

Innovation is high, shaped by rapid upgrades in powered motion systems, ADA-compliant design, advanced ergonomics, and integrated safety technologies. Manufacturers are adding low-entry heights, programmable positioning, Active Sensing Technology, wider transfer surfaces, and hygiene-centric materials. New powered chairs and compact multifunctional systems are improving clinical efficiency across ophthalmic, ENT, gynecologic, emergency, and outpatient settings. Expansion of programmable, fully electric systems and broader use of premium materials and modular accessories continue to elevate product sophistication.

M&A activity is moderate, primarily focused on expanding product portfolios, enhancing manufacturing capabilities, and strengthening distribution within surgical and outpatient care segments. Strategic collaborations-such as exclusive distribution agreements and facility expansions-remain more prevalent than large-scale acquisitions. Manufacturers partner with international chair specialists to introduce advanced multifunctional, powered, and specialty-specific procedure chairs to the U.S., reflecting targeted consolidation aimed at accelerating market penetration.

Regulatory influence is significant. Procedure chairs fall under FDA 21 CFR 880.6140 and must meet Class I device requirements. New U.S. Access Board standards, effective September 2024, mandate 17-inch low seat heights for accessible medical diagnostic equipment, influencing product redesigns and accelerating adoption of ADA-compliant models. Compliance with safety, structural, and ergonomic standards, plus facility accreditation and reimbursement frameworks (MS-DRG for inpatient, APC/OPPS for outpatient), increases design complexity and lengthens validation timelines. These regulatory obligations are driving manufacturers toward safer, more standardized, and accessibility-focused innovations.

The market is moderately concentrated, driven by a mix of established medical furniture manufacturers and specialized procedure-chair producers. Key players include Stryker, Midmark, MTI, Champion Manufacturing, UMF Medical, Haag-Streit Group, Infinium Medical, GF Health Products, and others. High-volume demand for powered chairs strengthens the position of firms offering advanced ergonomic systems, while diversified portfolios across ophthalmic, ENT, gynecological, and multifunctional treatment chairs allow leaders to maintain share across multiple clinical environments. Competition is shaped by innovation speed, regulatory compliance, facility partnerships, and the ability to provide durable, ADA-compliant, multi-specialty solutions.

Product Insights

The powered chairs segment held the largest revenue share in 2024. This dominance can be attributed to the growing demand for technologically advanced seating systems that enhance workflow efficiency and patient comfort in acute care settings. Powered procedure chairs offer superior adjustability, automated positioning, and smooth mobility, allowing clinicians to perform examinations and minor procedures with greater precision and reduced physical strain. Their ability to support rapid height adjustments, tilt functions, and multi-position configurations significantly improves patient accessibility, especially for individuals with limited mobility.

The manual chairs segment is expected to register the fastest growth rate during the forecast period. This segment is expanding as facilities prioritize reliable, low-maintenance equipment that supports high patient turnover and cost-efficient operations. Hospitals, emergency departments, and outpatient centers continue to adopt manual systems to reduce servicing needs and simplify workflow. Growth is supported by budget-constrained procurement cycles, increased use in routine procedures, and wider availability of ADA-aligned designs that improve accessibility. New product introductions focused on operational efficiency further strengthen demand and sustain segment momentum.

Application Insights

Multi-functional treatment chairs held the largest revenue share in 2024. This dominance can be attributed to the growing preference for versatile equipment that enables healthcare facilities to perform a wide range of procedures, including examinations, diagnostics, minor surgeries, and outpatient treatments, all on a single, adaptable platform. Multi-functional chairs enable transitions between various positions, reducing the need for multiple devices and helping hospitals optimize space, lower equipment costs, and enhance workflow efficiency. Their ergonomic design, advanced adjustability, and integration of features such as electronic controls, safety locks, and enhanced patient support systems also contribute to improved patient comfort and caregiver convenience.

The gynecological chairs segment is expected to register the fastest growth rate during the forecast period, supported by rising patient volumes across screening, diagnosis, and routine women’s health procedures. The increasing incidence of gynecological conditions and growing utilization of outpatient and hospital-based services are driving procurement. Providers are standardizing equipment to improve positioning consistency, room turnover, and workflow compliance. Expansion of specialty clinics and broader use of procedure-focused setups further strengthen segment demand.

End Use Insights

The acute care hospitals segment held the largest revenue share in 2024. This dominance can be attributed to the high patient inflow in hospital-based acute care departments, the rising number of surgical and minimally invasive procedures, and the greater emphasis on efficient patient handling and safety protocols. Acute care hospitals rely heavily on advanced procedure chairs to support rapid patient turnover, precise positioning, and seamless workflow integration across various departments. The availability of higher budgets in hospitals compared to other care settings also enables greater adoption of technologically advanced, powered, and ergonomic chair systems.

The ambulatory surgical centers segment is expected to register the fastest growth rate during the forecast period as procedure volumes continue shifting from inpatient to outpatient settings. ASCs are scaling capacity to manage higher surgical throughput, driving demand for procedure chairs that support efficient turnover and multi-specialty use. Expansion of Medicare-certified centers and broader adoption of same-day surgical models are increasing procurement. Standardization of equipment across new and existing facilities further supports sustained growth in this segment.

Key U.S. Acute Care Procedure Chair Company Insights

Key players in the U.S. market are expanding product portfolios, upgrading manufacturing capacity, and strengthening distribution reach across hospital, ASC, and outpatient settings. Companies such as Stryker, Champion Manufacturing, Midmark, MTI, UMF Medical, Infinium Medical, GF Health Products, Haag-Streit, and others are advancing powered-motion systems, improving ADA-aligned accessibility features, and integrating safety and workflow-support technologies. Firms are also investing in regulatory compliance, facility partnerships, and production expansions to support broader adoption across clinical specialties and high-throughput care environments.

Recent Developments

• In August 2025, UMF Medical introduced the LibertyPRO, a next-generation procedure chair series designed for versatility, durability, and enhanced patient comfort. Engineered with a 650 lb weight capacity to support a broad range of patient needs, LibertyPRO also offers optional TruComfort+ Support Rails with integrated blood pressure positioning to improve stability and help ensure more accurate vitals collection during procedures.

• In May 2025, Midmark Corp., a medical solutions provider committed to enhancing clinical environments and improving care delivery, introduced the Midmark 631 Procedure Chair as the first and only U.S. Access Board (USAB) compliant procedure chair. Designed to address growing accessibility needs in modern healthcare settings, the chair supports safer, more inclusive patient experiences while improving workflow efficiency for caregivers.

• In April 2025, UMF Medical introduced the FusionFREEDOM Exam Chair, designed to enhance accessibility for patients with mobility challenges and support more inclusive care environments. The chair features a low 17-inch seat height, optional TruComfort Support Rails to facilitate safe and secure transfers, and an ADA-compliant design, making it well-suited for practices prioritizing patient safety, comfort, and accessibility.

U.S. Acute Care Procedure Chair Market